This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Colgate (CL) Beats Q3 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Colgate-Palmolive's (CL) third-quarter 2023 organic sales advance 9% y/y, with improvements in the majority of divisions and categories.
PCE Numbers Come in Line With Expectations
by Zacks Equity Research
PCE Numbers Come in Line With Expectations.
PCE Index In-Line, +0.4%; Core YoY +3.7% - Lowest Since 2021
by Mark Vickery
Spending continued to climb: +0.7% compared with the +0.5% anticipated and the +0.4% posted a month ago.
Colgate-Palmolive (CL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
3 Soaps & Cleaning Materials Stocks to Watch in a Gloomy Industry
by Avisekh Bhattacharjee
The soap and cleaning materials industry is prone to elevated logistics, input and manufacturing costs amid supply-chain issues. Solid demand and marketing campaigns are likely to drive players like Procter & Gamble (PG), Colgate (CL) and Church & Dwight (CHD).
Colgate-Palmolive (CL) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 7.50% and 2.06%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Colgate-Palmolive (CL) Ahead of Earnings?
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) first-quarter performance will likely reflect economic hurdles in China, volatile inflation levels and foreign currency fluctuations.
What Awaits Sysco (SYY) as It Readies for Q1 Earnings Release?
by Zacks Equity Research
Sysco's (SYY) first-quarter results are likely to reflect gains from the Recipe for Growth program amid soft industry volumes.
Things You Need to Know Before Newell's (NWL) Q3 Earnings
by Zacks Equity Research
Continued inflationary pressures are likely to have dented Newell's (NWL) Q3 earnings despite productivity and efficiency initiatives.
Colgate (CL) Poised for Q3 Earnings Beat on Business Momentum
by Zacks Equity Research
Colgate's (CL) Q3 results are expected to reflect gains from pricing actions, accelerated revenue growth management plans, product innovation and expansion efforts.
Factors Likely to Influence Hershey's (HSY) Q3 Earnings
by Zacks Equity Research
The Hershey Company's (HSY) third-quarter performance is likely to reflect gains from solid demand and pricing actions. Prudent buyouts have also been a driver.
Columbia Sportswear (COLM) Readies for Q3 Earnings: What Awaits?
by Zacks Equity Research
Columbia Sportswear's (COLM) third-quarter results are likely to reflect gains from the DTC channel and brand strength amid high SG&A costs.
Chef's Warehouse (CHEF) Q3 Earnings Coming Up: What to Expect
by Zacks Equity Research
Chef's Warehouse's (CHEF) third-quarter 2023 sales results are likely to reflect gains from the sturdy execution of its strategic and expansion initiatives.
Colgate-Palmolive (CL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What to Know About Altria (MO) as It Queues for Q3 Earnings?
by Zacks Equity Research
Altria's (MO) third-quarter results are likely to reflect gains from pricing and strength in oral tobacco products amid soft cigarette volumes.
Can Keurig Dr Pepper (KDP) Beat on Q3 Earnings Amid Inflation?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results are expected to reflect gains from continued brand strength, significant pricing actions, a solid performance in its cold beverages and strong market share gains.
Brand Strength & Pricing to Aid Boston Beer's (SAM) Q3 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q3 results are expected to reflect the momentum in the Twisted Tea brand, innovation, its intensified attention to pricing and product portfolio expansion efforts.
Can Archer Daniels (ADM) Retain Its Earnings Beat Trend in Q3?
by Zacks Equity Research
A solid product portfolio, improved crush margins and resilient food demand are likely to aid Archer Daniels' (ADM) Q3 results amid inflation challenges and a soft Nutrition segment performance.
Can Coca-Cola (KO) Q3 Earnings Beat Countering Inflation Woes?
by Zacks Equity Research
Coca-Cola's (KO) Q3 results are likely to reflect the benefits of strength across markets, and gains from innovations and accelerating digital investments, offset by inflationary pressures and higher SG&A.
Simply Good Foods (SMPL) Q4 Earnings Coming Up: What to Expect
by Zacks Equity Research
Simply Good Foods' (SMPL) fourth-quarter fiscal 2023 results are likely to reflect gains from brand-building initiatives and cost-controlling efforts.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Procter & Gamble (PG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 7.02% and 1.03%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Smoke-Free Products Fuel Philip Morris' (PM) Q3 Earnings?
by Zacks Equity Research
Philip Morris (PM) benefits from strength in the smoke-free product unit due to consumers' growing inclination toward health and wellness.
What Awaits Philip Morris (PM) as It Queues for Q3 Earnings?
by Zacks Equity Research
Philip Morris' (PM) third-quarter results are likely to reflect gains from pricing as well as strength in smoke-free products amid soft cigarette volumes.